Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Psychophysiology|December 17, 2024
Unexpected sounds induce a rapid inhibition of eye-movement responsesMartin R Vasilev, Zeynep G Ozkan, Julie A Kirkby, et al.
Scientific Reports|December 12, 2022
Distraction by deviant sounds is modulated by the environmental contextFabrice B R Parmentier, Laura Gallego, Antonia Micucci, et al.
Frontiers in Psychology|March 26, 2019
Mindfulness and Symptoms of Depression and Anxiety in the General Population: The Mediating Roles of Worry, Rumination, Reappraisal and SuppressionFabrice B R Parmentier, Mauro García-Toro, Javier García-Campayo, et al.
Neuropsychologia|September 28, 2010
Explicit processing of verbal and spatial features during letter-location binding modulates oscillatory activity of a fronto-parietal networkClaudia Poch, Pablo Campo, Fabrice B R Parmentier, et al.
Journal of Clinical Medicine|April 30, 2021
Assessing the Impact of Multi-Morbidity and Related Constructs on Patient Reported Safety in Primary Care: Generalized Structural Equation Modelling of Observational DataIgnacio Ricci-Cabello, Aina María Yañez-Juan, Maria A Fiol-deRoque, et al.
Biochemical Pharmacology|February 10, 2007
The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disordersR Parmentier, C Anaclet, C Guhennec, et al.
Neuroimage|October 21, 2009
Oscillatory activity in prefrontal and posterior regions during implicit letter-location bindingPablo Campo, Claudia Poch, Fabrice B R Parmentier, et al.
Attention, Perception & Psychophysics|June 9, 2025
Figure disembedding facility and reduced left visual field bias are linked to the social dimension of autistic traitsMichael C W English, Isabelle M Raiter, Nigel T M Chen, et al.
British Journal of Pharmacology|May 6, 2009
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- miceR X Guo, C Anaclet, J C Roberts, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2006
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacologyX Ligneau, D Perrin, L Landais, et al.
Pageof 9